Even after excluding the TNF inhibitor group, the Kaplan–Meier curve indicated a higher ILD progression rate in the csDMARD-only group; however, this difference remained statistically non-significant (p = 0.56 by log-rank test; Figure 2). Here, TNF is linked to interstitial lung disease.